Ontario, NY, United States of America

Ernest S Smith

USPTO Granted Patents = 45 

 

 

Average Co-Inventor Count = 2.9

ph-index = 12

Forward Citations = 335(Granted Patents)


Location History:

  • Ontario, NY (US) (2006 - 2018)
  • Rochester, NY (US) (2016 - 2024)
  • W. Henrietta, NY (US) (2019 - 2024)
  • West Henrietta, NY (US) (2023 - 2024)

Company Filing History:


Years Active: 2006-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Semaphorin-4D Antibodies
Anti-CD100 Antibodies
Tumor Growth Inhibition
Neurodegenerative Disorders
Immune Modulating Therapy
Poxvirus Protein Display
CXCL13 Antibodies
B Cell-Mediated Inflammation
VEGF Inhibitory Molecules
Immunoglobulin Selection
Angiogenesis Inhibition
Monoclonal Antibodies
45 patents (USPTO):Explore Patents

Title: The Innovations and Contributions of Ernest S. Smith

Introduction

Ernest S. Smith is a notable inventor based in Ontario, NY, recognized for his significant contributions to the field of biomedicine. With an impressive portfolio of 42 patents, Smith has developed groundbreaking technologies that aim to address various medical challenges, particularly in the realm of immunology and cancer treatment.

Latest Patents

Among his latest innovations are two noteworthy patents that reflect his expertise and commitment to advancing medical science. The first patent, titled "Anti-CD100 antibodies and methods for using the same," offers compositions and methods for treating diseases associated with CD100, including autoimmune and inflammatory diseases, as well as certain cancers. This invention focuses on the development of anti-CD100 monoclonal antibodies designed to neutralize CD100, showcasing Smith’s dedication to improving therapeutic options for patients.

The second patent, "Integral membrane protein display on poxvirus extracellular enveloped virions," provides a method for expressing and displaying isolated integral membrane proteins (IMPs) in their native conformation on poxvirus extracellular virions. This technology presents innovative approaches for screening, selecting, and identifying antibodies that target specific IMPs, paving the way for new diagnostic and therapeutic strategies.

Career Highlights

Throughout his career, Ernest S. Smith has worked with prominent organizations such as Vaccinex, Inc., and the University of Rochester, where he has contributed to significant research initiatives. His work in these institutions has fostered the development of essential technologies and therapeutic strategies aimed at improving patient outcomes in complex diseases.

Collaborations

Smith’s journey in the innovation landscape has been enriched through collaborations with esteemed colleagues, including Maurice Zauderer and Mark Paris. These partnerships have enabled the cross-pollination of ideas and techniques, further enhancing the impact of their joint research endeavors.

Conclusion

In summary, Ernest S. Smith stands out as a pioneering inventor whose work continues to influence the fields of immunology and biotechnology. His extensive patent portfolio signifies his commitment to creating innovative solutions that address pressing medical challenges. As the landscape of medicine evolves, Smith's contributions will undoubtedly play a pivotal role in shaping future treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…